PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Metoject (Rheumatism)
Presentation Product Chemical substance Chapter Items dispensed
Metoject PEN 20mg/0.4ml inj pre-filled pens
1001030U0BEARBW
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 25,425
Metoject PEN 25mg/0.5ml inj pre-filled pens
1001030U0BEAWCB
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 18,503
Metoject PEN 15mg/0.3ml inj pre-filled pens
1001030U0BEAXCC
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 17,726
Metoject PEN 10mg/0.2ml inj pre-filled pens
1001030U0BEAZCE
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 7,524
Metoject PEN 17.5mg/0.35ml inj pre-filled pens
1001030U0BEAQBV
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4,908
Metoject PEN 12.5mg/0.25ml inj pre-filled pens
1001030U0BEAYCD
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4,123
Metoject PEN 22.5mg/0.45ml inj pre-filled pens
1001030U0BEASBX
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2,976
Metoject PEN 7.5mg/0.15ml inj pre-filled pens
1001030U0BEATBY
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2,476
Metoject PEN 30mg/0.6ml inj pre-filled pens
1001030U0BEAVCA
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 117
Metoject PEN 27.5mg/0.55ml inj pre-filled pens
1001030U0BEAUBZ
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 39
Metoject 25mg/0.5ml inj pre-filled syringes
1001030U0BEAJBI
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 9
Metoject 15mg/0.3ml inj pre-filled syringes
1001030U0BEAHBG
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4
Metoject 17.5mg/0.35ml inj pre-filled syringes
1001030U0BEAMBL
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3
Metoject 20mg/0.4ml inj pre-filled syringes
1001030U0BEAIBH
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3
Metoject 10mg/0.2ml inj pre-filled syringes
1001030U0BEAGBF
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 1
Metoject 10mg/1ml solution for injection pre-filled syringes
1001030U0BEACBB
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 12.5mg/0.25ml inj pre-filled syringes
1001030U0BEALBK
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 15mg/1.5ml inj pre-filled syringes
1001030U0BEADBC
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 20mg/2ml solution for injection pre-filled syringes
1001030U0BEABBA
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 22.5mg/0.45ml inj pre-filled syringes
1001030U0BEANBM
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 25mg/2.5ml inj pre-filled syringes
1001030U0BEAEBD
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 27.5mg/0.55ml inj pre-filled syringes
1001030U0BEAPBN
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 30mg/0.6ml inj pre-filled syringes
1001030U0BEAKBJ
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 7.5mg/0.15ml inj pre-filled syringes
1001030U0BEAFBE
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Metoject 7.5mg/0.75ml inj pre-filled syringes
1001030U0BEAAAZ
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.